Results 371 to 380 of about 185,125 (388)

Anaphylactic Reactions to Proton-Pump Inhibitors

Annals of Pharmacotherapy, 2000
OBJECTIVE: To report two cases of anaphylactic reactions to proton-pump inhibitors (PPIs). CASE SUMMARIES: A 54-year-old woman who had taken omeprazole in the past was treated with omeprazole 40 mg and developed periorbital edema, edema of the skin, pruritus, nausea, and vomiting about 45 minutes after taking one capsule.
Natsch, S.S., Vinks, M.H.A.M., Voogt, A.K., Mees, E.B., Meyboom, R.H.B.   +4 more
openaire   +4 more sources

Proton Pump Inhibitors

1999
The discovery and development of the proton pump inhibitor.- The discovery and development of the proton pump inhibitor.- Mechanism of action.- The gastric H, K ATPase.- Inhibition of the gastric proton pump.- The Pharmacology of proton pump inhibitors.- Inhibition of gastric acid secretion.- Consequences of gastric acid inihibition in animals ...
openaire   +2 more sources

The appropriate use of proton-pump inhibitors

Minerva Medica, 2018
The introduction of proton-pump inhibitors (PPIs) into clinical practice since about thirty years has greatly improved our therapeutic approach to acid-related diseases for their well recognized efficacy and safety. Accordingly, the role of surgery has been enormously reduced in this field.
Savarino, Vincenzo, Marabotto, Elisa, Zentilin, Patrizia, Furnari, Manuele, Bodini, Giorgia, De Maria, Costanza, Pellegatta, Gaia, Coppo, Claudia, Savarino, Edoardo   +8 more
openaire   +3 more sources

Lansoprazole: A Proton Pump Inhibitor

Annals of Pharmacotherapy, 1996
OBJECTIVE: To summarize the published data on lansoprazole, a proton pump inhibitor approved by the Food and Drug Administration for use in the treatment of duodenal ulcer, erosive esophagitis, and pathologic hypersecretory conditions (e.g., Zollinger-Ellison syndrome).
openaire   +3 more sources

An Overview of Proton Pump Inhibitors

Gastroenterology Nursing, 2003
Proton pump inhibitors are the standard of treatment for acid-related disorders. These disorders include gastroesophageal reflux disease and its complications (i.e., erosive esophagitis and Barrett's esophagus), peptic ulcer disease, Zollinger-Ellison syndrome, and idiopathic hypersecretion.
openaire   +2 more sources

Proton pump inhibitors

Medical Journal of Australia, 1998
openaire   +3 more sources

Deprescribing Proton Pump Inhibitors

JAMA Internal Medicine, 2020
Sameer D. Saini, Jacob E. Kurlander, Juan J. Gonzalez   +2 more
openaire   +2 more sources

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use

Digestion, 2018
Y. Naito, Kaori Kashiwagi, T. Takagi, A. Andoh, R. Inoue   +4 more
semanticscholar   +1 more source

Overuse of proton pump inhibitors

Journal of Clinical Pharmacy and Therapeutics, 2008
Gregory M. Peterson, Mark Naunton, Martin D. Bleasel   +2 more
openaire   +2 more sources

Proton Pump Inhibitors and Mortality

Gastroenterology, 2023
Helge L. Waldum, Reidar Fossmark
openaire   +2 more sources